[French pediatric oncology: analysis of the present situation and future prospects].
In France, the cure rate of paediatric malignancies is presently above 70%. The main contributing factors of the major improvement in the management of paediatric malignancies in recent years have been the development of a multicentric national and international clinical research, and the setting up of a network of multidisciplinary teams covering the whole country and working with technology transfer laboratories. The French group of study of cancers and leukemias in childhood works on the structuring of the French paediatric oncology on the three following themes: 1) the definition of the criteria required to be recognised as a reference centre in paediatric oncology; 2) the training of the future paediatricians specialised in haematology and oncology; and 3) the modalities of development and financial support of the clinical research. This paper mainly concerns the first point. Based on a national questionnaire survey, the measures needed to improve the organisation of the paediatric hyperspecialties are presented.
Sommelet
D
D
Service d'onco-immuno-hématologie pédiatrique, centre hospitalier universitaire, hôpital d'Enfants, rue du Morvan, 54511 Vandoeuvre-lés-Nancy, France.
D002648:Child; D004059:Diffusion of Innovation; D004501:Education, Medical; D005602:France; D006801:Humans; D007400:Interprofessional Relations; D008495:Medical Oncology / Q000458:organization & administration / Q000639:trends*; D009369:Neoplasms / Q000628:therapy; D010372:Pediatrics / Q000193:education / Q000458:organization & administration / Q000639:trends*